Boson Biotech. Co., Ltd
Boson Biotech Co., Ltd is a China-based company located in Xiamen that specializes in the development and manufacture of rapid immunoassay test kits for the in vitro diagnostic market. The company operates with a focus on high-quality point-of-care and immunoassay solutions designed for worldwide distribution, supported by an established branch in the United States under Lumiquick Diagnostic Inc.
Product Focus and Capabilities
Boson Biotech’s primary product families include rapid infectious disease tests (such as HIV, HBV, HCV, Dengue, Malaria, Tuberculosis, and Influenza), rapid cardiac marker tests (Troponin, Myoglobin, CK-MB), rapid cancer marker tests (FOB, PSA, AFP, CEA), rapid drugs of abuse tests (a broad panel including Tramadol, Cocaine, Methadone, MDMA, and others), and rapid fertility hormone tests (HCG, LH, TSH). These offerings are aligned with the needs of hospitals, clinics, and laboratories that require quick, reliable results for diagnostic decision-making.
Quality and Compliance
The company operates under quality and regulatory frameworks including ISO 13485:2003, GMP, and CE certifications. These standards underscore a commitment to meeting international requirements for medical device manufacturing and ensure that products are suitable for European, Middle Eastern, Asian, and African markets. The combination of certifications supports Boson Biotech’s ability to supply a diverse, global customer base with immunoassay-based solutions.
Global Footprint and Partnerships
Boson Biotech maintains a global outlook through its US branch, Lumiquick Diagnostic Inc., which supports its international distribution and market access. This arrangement suggests an emphasis on expanding regional reach and leveraging strategic collaborations to address demand in different markets.
Company Culture and Philosophy
Website and public materials emphasize teamwork, a customer-focused mindset, and an entrepreneurial spirit. The company promotes a collaborative approach, endorsing values such as collective success, a belief in people, and a willingness to stand up for ideas and engage others in the process of innovation. While these elements reflect organizational culture, they are presented in a broader, non-promotional context.
Market Position and Outlook
With a portfolio centered on rapid diagnostic solutions, Boson Biotech aims to serve global healthcare providers by delivering high-quality immunoassay kits for infectious diseases, cancer markers, cardiac markers, drugs of abuse, and fertility hormones. The presence of an international branch signals a strategy to broaden geographic reach and support a diversified customer base across multiple regions.
In summary, Boson Biotech Co., Ltd combines specialized in vitro diagnostic kit development with certified quality management, enabling its products to reach global markets from its Xiamen base and its US subsidiary. The focus on rapid immunoassay solutions positions the company within the growing segment of point-of-care diagnostics and rapid testing originally designed for quick clinical decision-making.
